CancerAppy
Novel cancer therapeutic drugs
At CancerAppy, we specialize in cancer research, dedicated to discovering and developing new therapeutic targets. Our proprietary artificial intelligence methodology allows us to accelerate advancements in more effective cancer treatments
Driving innovation in breakthrough oncology treatments.
With our deep expertise in oncology and AI, we analyze vast amounts of multimodal data using advanced AI algorithms. This allows us to identify new therapeutic targets, discover lead compounds, understand their mechanisms of action, and explore potential drug combinations. Our technology also enables the development of next-generation antibody-drug conjugates (ADCs), driving more precise and effective cancer treatments.
We work in the early stage of the Drug Discovery Value Chain.
Our R&D Pipeline
At CancerAppy, we use AI-driven drug discovery to develop new cancer therapies, including novel ADCs (antibody-drug conjugates). Our pipeline moves from target discovery to preclinical development, bringing innovative treatments closer to patients.
News
Latest news about CancerAppy…
B-Venture 2020 – Bilbao
Cancerappy had the opportunity to present its project as it was one of the 24 startups selected to present in this year's edition of B-Venture2020...
Meet Sarah…
Meet Sarah. She's a scientist who does research on medications that treat cancer. Now Sarah's a busy woman, so she doesn't have the 21 hours a day...
Pre-seed round
CancerAppy raised a pre-seed round of € 120K. In the middle of the Covid pandemic and with the lockdown active, the CancerAppy team, led by its CEO...
Grant CPP2021-008597 funded by:
Grant TQ2020-011486 funded by:
Subvencionado por el CDTI
Somos cliente Enisa
